Last reviewed · How we verify
NCT04688502
Effects of Wearing a Face Mask During CrossFit Exercise
NA trial testing High intensity interval training in Dyspnea. Withdrawn.
28 January 2023
Quick facts
| Lead sponsor | University of Saskatchewan |
|---|---|
| Phase | NA |
| Status | Withdrawn |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | single |
| Primary purpose | prevention |
| Start date | 11 June 2022 |
| Primary completion | 28 January 2023 |
| Estimated completion | 15 February 2023 |
| Sites | 1 location across Canada |
Drugs / interventions tested
- High intensity interval training
- Continuous exercise training
Conditions studied
- Dyspnea — all drugs for Dyspnea →
Sponsor
University of Saskatchewan
Who can join
18 and older, any sex, with Dyspnea. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Face masks are important for prevention of transmission and contracting viruses such as COVID-19. Gymnasiums have been identified as being susceptible to virus transmission; therefore, wearing face masks during exercise is important during pandemics. This study will evaluate performance and physiological stress during high-intensity exercise while wearing a face mask during Crossfit exercise training.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04688502
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of High intensity interval training
Trials testing the same drug.
- NCT07153523 — Effect of High Intensity Interval Training on Strength, Endurance and Flexibility · NA · recruiting
- NCT07328568 — Effect of Low Volume Sprint Interval Training on Cardiorespiratory Fitness · NA · active not recruiting
- NCT07025694 — Exercise Training Among Children With Cerebral Palsy to Increase Health and Well-being - A Feasibility Study · NA · recruiting
- NCT06509464 — Response Of Metabolic Syndrome Severity Score To High Intenisty Interval Training In Women With Central Obesity. · NA · recruiting
- NCT07046520 — Effects of HIIT on Plasma Volume and Aerobic Capacity in Obese Adolescent Girls · NA · completed
Other recruiting trials for Dyspnea
Currently open trials in the same condition.
- NCT07386444 — Inspiratory Muscle Training for Breast Cancer Patients on Chemotherapy · NA · recruiting
- NCT06807983 — LUng and Cardiac Ultrasound for REspiratory Distress in ElDerly · NA · recruiting
- NCT07104578 — Evaluation of the Impact of Pleuropulmonary Ultrasound on the Diagnosis of Dyspnea · recruiting
- NCT07268859 — Effect of Fan Application in Preventing Ticagrelor-Associated Dyspnea · NA · recruiting
- NCT06556797 — Proof-of-concept Study on Dyspnea Analysis Via GapCO2 · recruiting
Other University of Saskatchewan trials
Trials by the same sponsor.
- NCT07433686 — Saskatoon Berry Juice for Muscle Recovery · NA · not yet recruiting
- NCT07489469 — Effectiveness of an AI Scribe Compared to Routine Templates for Clinical Documentation in Orthopedic Consultations · NA · completed
- NCT06946316 — Dairy vs Plant-based Beverages for Improving Bone Health During Exercise · NA · recruiting
- NCT04276857 — Systemic Therapy With a Loco-regional Treatment in Patients With Locally Advanced Pancreatic Cancer · NA · recruiting
- NCT03401294 — Conversion From Unresectable To Resectable Metastatic Colorectal Cancer. · Phase 2 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04688502 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Saskatchewan
- Last refreshed: 24 April 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04688502.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing